KELLY SHARKEY: Open Payments
NPI 1336327022 · GLENDORA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 6 payments from 4 companies in 2025. Trend: 2023 $648 · 2024 $153 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $125 |
| ABBVIE INC. | 1 | $106 |
| Amgen Inc. | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: Ozempic, VRAYLAR, OTEZLA, REPATHA, REXULTI.
Industry payments across NJ — which companies pay providers there.
